Showing results (351-360 of 666) with videos related to

Sort By:
Pageof 67
The Annals of Thoracic Surgery|April 1, 1995
Characteristics of nine newly derived mesothelioma cell linesH I Pass, E J Stevens, H Oie, et al.
The American Journal of Surgical Pathology|July 1, 1990
Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomasW D Travis, S Pittaluga, G Y Lipschik, et al.
Annals of Surgery|November 1, 1990
Surgical management of pheochromocytoma with the use of metyrosineR R Perry, H R Keiser, J A Norton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Debrisoquine metabolism and lung cancer riskG L Shaw, R T Falk, J Deslauriers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Genetic polymorphism of CYP2D6 and lung cancer riskG L Shaw, R T Falk, J N Frame, et al.
Radiology|July 11, 1992
Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous samplingJ L Doppman, H I Pass, L K Nieman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 1, 1990
Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alphaS C Yang, K D Fry, E A Grimm, et al.
Journal of Surgical Oncology|January 1, 1975
Restoration of immunocompetency by lymphocyte transfusionJ A Roth, M J Silverstein, R K Gupta, et al.
The Journal of Biological Chemistry|July 27, 1999
Melatonin promotes osteoblast differentiation and bone formationJ A Roth, B G Kim, W L Lin, et al.
Gene Therapy|August 6, 1999
Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacementL Ji, M Bouvet, R E Price, et al.
Pageof 67